The international twitter based rheumatology journal club will hold its next session this tuesday to discuss the paper “Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis” published in Arthritis and Rheumatology. The full text paper has been made available until the 6th March by the Wiley publishing group — you can find it here.

There will be two one-hour “live chats”, the first being at 8pm GMT (3pm EST) where lead author of the paper Dr. Eli Miloslavsky (@emilosla) will be available to answer questions. A second session will occur at 2am GMT (9pm EST). The session will last for a full 24 hours in an asynchronous format so that anyone who wants to participate can.

The hashtag for the journal club is #rheumjc. The session will conclude at 8pm GMT on March 4th with a summary of the entire session.